Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Other acquisition Director acquired 299 shares (code L)
  2. 4 Other acquisition Chairman and CEO acquired 299 shares (code L)
  3. 4 Other acquisition Director acquired 1,564 shares (code L)
  4. 4 Other acquisition Director acquired 88 shares (code L)
  5. 4 Other acquisition Director acquired 254 shares (code L)
  6. 4 Other acquisition Chairman and CEO acquired 254 shares (code L)
  7. 4 Other acquisition Director acquired 1,314 shares (code L)
  8. 4 Open-market buy Director bought 121 shares at an average $3.29 ($398)
  9. 4 Open-market buy Director bought 262 shares at an average $3.29 ($862)
  10. 4 Open-market buy Chairman and CEO bought 262 shares at an average $3.29 ($862)
  11. 4 Open-market buy Director bought 1,372 shares at an average $3.29 ($4,516)
  12. 4 Open-market buy Director bought 168 shares at an average $3.44 ($578)
  13. 4 Open-market buy Director bought 340 shares at an average $3.43 ($1,166)
  14. 4 Open-market buy Chairman and CEO bought 340 shares at an average $3.43 ($1,166)
  15. 4 Open-market buy Director bought 1,712 shares at an average $3.43 ($5,872)
  16. 4 Open-market buy Director bought 84 shares at an average $4.80 ($404)
  17. 4 Open-market buy Chairman and CEO bought 168 shares at an average $4.80 ($807)
  18. 4 Open-market buy Director bought 168 shares at an average $4.80 ($807)
  19. 4 Open-market buy Director bought 935 shares at an average $4.83 ($4,513)
  20. 4 Open-market buy Director bought 945 shares at an average $5.11 ($4,824)

Page 2 of 26 · 512 filings